Europe, MEA Substance Abuse Treatment Market Size (2024 - 2029)

The Europe, Middle East, and Africa substance abuse treatment market is anticipated to experience substantial growth, driven by increased awareness campaigns and a rising number of treatment centers. The market's expansion is influenced by the heightened substance dependence observed during and after the COVID-19 pandemic, which spurred a surge in binge drinking and drug use. Despite challenges such as the discontinuation of behavioral therapies and poor treatment compliance in some regions, the market is poised for growth due to government interventions and the establishment of more treatment facilities.

Market Size of Europe, MEA Substance Abuse Treatment Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Europe, MEA Substance Abuse Treatment Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 9.00 %
Market Concentration Medium

Major Players

Europe, MEA Substance Abuse Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe, MEA Substance Abuse Treatment Market Analysis

The Europe, Middle East, and Africa substance abuse treatment market is expected to witness a CAGR of 9.0% over the forecast period.

  • COVID-19 had a significant impact on the Europe, Middle East, and Africa substance abuse treatment market since there was a big increase in binge drinking during COVID-19. For instance, as per the February 2021 update by Randox Technology, the impact of COVID-19 on drug usage in Europe varied depending on the drug in consideration. Overall, 51.6% of survey respondents reported increasing their drug or alcohol intake, and 57.3% reported using drugs more often.
  • The main explanations for these trends are boredom and anxiety, most likely as a result of the imposed limits of severe lockdown measures. However, as the pandemic restrictions eased, the Europe, Middle East, and Africa substance abuse treatment market is expected to witness growth in the market due to the increase in awareness campaigns regarding substance abuse and the increase in substance dependence among the population.
  • Certain factors that are driving the market growth include rising drug awareness campaigns and prevention programs, a high number of addicted populations, and a rise in research and development of substance abuse treatment. For instance, as per the European Drug Report 2022, approximately 83.4 million or 29 % of adults (aged 15-64) in the European Union were estimated to use an illicit drug, with more males (50.5 million) than females (33.0 million) reporting use. Cannabis remains the most widely consumed substance, with over 22 million European adults reporting its use in 2021. Hence, a high number of substances used in the European region is expected to increase the demand for substance abuse treatment over the forecast period.
  • Furthermore, the rise in drug awareness campaigns and associated prevention programs is one of the primary factors linked to the growth of the market studied. It includes rising patient awareness, a higher treatment-seeking rate with increased government intervention, and encouragement to curb substance abuse in several countries. For instance, in May 2021, the National Rehabilitation Centre (NRC), a World Health Organization (WHO) Collaborating Centre of Excellence in the field of substance abuse in the Middle East, organized a capacity-building training event in the field of drug and alcohol abuse prevention.
  • Additionally, an increasing number of treatment centers that have collaborations with private recovery facilities are entering the market, thus helping in the expansion of treatment access to a higher number of people in society. For instance, in October 2022, the Gauteng Provincial Government launched the substance abuse helpline in line with Premier Panyaza Lesufi's commitment to intensify the fight against substance abuse across Gauteng.
  • Hence, due to the increase in substance use and a rise in awareness programs against drug abuse, the studied market is likely to witness significant growth over the forecast period. However, the discontinuation of behavioral therapies and poor treatment compliance in some countries hinder the growth of the market studied.

Europe, MEA Substance Abuse Treatment Industry Segmentation

Substance abuse refers to the use of psychoactive substances, including illicit drugs, tobacco, and alcohol. Excessive use of a psychoactive substance can lead to major health and social issues, which, in some cases, can even lead to critical ailments and death. 

The Europe, Middle East, and Africa substance abuse treatment market is segmented by abuse type (alcohol dependence, tobacco/nicotine addiction, opioid addiction, other abuse types), treatment (alcohol addiction treatment, tobacco/nicotine addiction treatment (nicotine replacement treatment, non-nicotine medication, other tobacco/nicotine addiction treatments), drug abuse treatment, other treatment types), distribution channel (hospital pharmacies, retail pharmacies, other distribution channels), and geography (Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa)). 

The report offers the value (in USD) for the above segments.

By Abuse Type
Alcohol Dependence
Tobacco/Nicotine Addiction
Opioid Addiction
Other Abuse Types
By Treatment
Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Nicotine Replacement Treatment
Non-nicotine Medication
Other Tobacco/Nicotine Addiction Treatments
Drug Abuse Treatment
Other Treatment Types
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Europe, MEA Substance Abuse Treatment Market Size Summary

The Europe, Middle East, and Africa substance abuse treatment market is poised for significant growth, driven by an increasing prevalence of substance use and heightened awareness campaigns. The COVID-19 pandemic exacerbated substance abuse issues, with a notable rise in binge drinking and drug use, prompting a surge in demand for treatment solutions. As restrictions eased, the market began to expand, supported by government initiatives and awareness programs aimed at reducing substance dependence. The market's growth is further bolstered by the development of new treatment centers and collaborations with private recovery facilities, enhancing access to treatment across the region. However, challenges such as the discontinuation of behavioral therapies and poor treatment compliance in certain areas continue to pose obstacles to market expansion.

The nicotine replacement therapy segment is expected to capture a significant share of the market, fueled by the rising tobacco use and the introduction of new products in Europe and the Middle East. The availability of nicotine in various forms, such as gum and patches, without the harmful chemicals found in tobacco, is driving the adoption of these therapies. The United Kingdom is anticipated to experience notable market growth due to the increasing prevalence of drug use and the implementation of extensive awareness programs. Government funding and strategic initiatives aimed at rebuilding the drug treatment system further support the market's expansion. The competitive landscape is characterized by the presence of major players, including Alkermes PLC, Abbvie, and GSK plc, who are actively involved in shaping the market dynamics through innovative solutions and strategic partnerships.

Explore More

Europe, MEA Substance Abuse Treatment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Drug Awareness Campaigns and Prevention Programs

      2. 1.2.2 High Number of Drug Addicted Population

      3. 1.2.3 Rise in Research and Development for the Substance Abuse Treatment

    3. 1.3 Market Restraints

      1. 1.3.1 Reluctance of Individuals for Accessing Treatment and Discontinuation of the Behavioral Therapies

      2. 1.3.2 Poor Treatment Compliance in Some Countries

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Abuse Type

      1. 2.1.1 Alcohol Dependence

      2. 2.1.2 Tobacco/Nicotine Addiction

      3. 2.1.3 Opioid Addiction

      4. 2.1.4 Other Abuse Types

    2. 2.2 By Treatment

      1. 2.2.1 Alcohol Addiction Treatment

      2. 2.2.2 Tobacco/Nicotine Addiction Treatment

        1. 2.2.2.1 Nicotine Replacement Treatment

        2. 2.2.2.2 Non-nicotine Medication

        3. 2.2.2.3 Other Tobacco/Nicotine Addiction Treatments

      3. 2.2.3 Drug Abuse Treatment

      4. 2.2.4 Other Treatment Types

    3. 2.3 By Distribution Channel

      1. 2.3.1 Hospital Pharmacies

      2. 2.3.2 Retail Pharmacies

      3. 2.3.3 Other Distribution Channels

    4. 2.4 Geography

      1. 2.4.1 Europe

        1. 2.4.1.1 Germany

        2. 2.4.1.2 United Kingdom

        3. 2.4.1.3 France

        4. 2.4.1.4 Italy

        5. 2.4.1.5 Spain

        6. 2.4.1.6 Rest of Europe

      2. 2.4.2 Middle East and Africa

        1. 2.4.2.1 GCC

        2. 2.4.2.2 South Africa

        3. 2.4.2.3 Rest of Middle East and Africa

Europe, MEA Substance Abuse Treatment Market Size FAQs

The Europe, MEA Substance Abuse Treatment Market is projected to register a CAGR of 9% during the forecast period (2024-2029)

Mallinckrodt LLC, Indivior PLC, Alkermes PLC, Viatris and GSK plc are the major companies operating in the Europe, MEA Substance Abuse Treatment Market.

Europe, Middle East & Africa Substance Abuse Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)